Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging
- PMID: 32578891
- DOI: 10.1111/his.14140
Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging
Abstract
Aims: Precise evaluation of proliferative activity is essential for the stratified treatment of luminal-type breast cancer (BC). Immunohistochemical staining of Ki-67 has been widely used to determine proliferative activity and is recognised to be a useful prognostic marker. However, there remains discussion concerning the methodology. We aimed to develop an automated and reliable Ki-67 assessment approach for invasive BC.
Materials and results: A retrospective study was designed to include two cohorts consisting of 152 and 261 consecutive patients with luminal-type BC. Representative tissue blocks following surgery were collected, and three serial sections were stained automatically with Ki-67, pan-cytokeratin and p63. The whole slides were scanned digitally and aligned using VirtualTripleStaining - an extension to the VirtualDoubleStaining™ technique provided by Visiopharm software. The aligned files underwent automated invasive cancer detection, hot-spot identification and Ki-67 counting. The automated scores showed a significant positive correlation with the pathologists' scores (r = 0.82, P < 0.0001). Among selected patients with curative surgery and standard adjuvant therapies (n = 130), the digitally assessed low Ki-67 group (<20%) demonstrated a significantly better prognosis (breast cancer-specific survival, P = 0.030; hazard ratio = 0.038) than the high Ki-67 group.
Conclusions: Digital image analysis yielded similar results to the scores determined by experienced pathologists. The prognostic utility was verified in our cohort, and an automated process is expected to have high reproducibility. Although some pitfalls were confirmed and thus need to be monitored by laboratory staff, the application could be utilised for the assessment of BC.
Keywords: Ki-67; automated pathology; digital image analysis; luminal-type breast cancer; standardisation; virtual triple staining.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms.J Am Soc Cytopathol. 2024 May-Jun;13(3):205-212. doi: 10.1016/j.jasc.2024.02.001. Epub 2024 Feb 10. J Am Soc Cytopathol. 2024. PMID: 38433072
-
A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.PLoS One. 2016 Feb 29;11(2):e0150505. doi: 10.1371/journal.pone.0150505. eCollection 2016. PLoS One. 2016. PMID: 26928407 Free PMC article.
-
Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.Pathol Oncol Res. 2018 Jan;24(1):115-127. doi: 10.1007/s12253-017-0220-8. Epub 2017 Apr 11. Pathol Oncol Res. 2018. PMID: 28401450
-
Artificial intelligence-powered optimization of KI-67 assessment in breast cancer: enhancing precision and workflow efficiency. a literature review.J Pak Med Assoc. 2024 Apr;74(4 (Supple-4)):S109-S116. doi: 10.47391/JPMA.AKU-9S-12. J Pak Med Assoc. 2024. PMID: 38712418 Review.
-
A semi-automated microscopic image analysis method for scoring Ki-67 nuclear immunostaining.Braz J Med Biol Res. 2023 Nov 13;56:e12922. doi: 10.1590/1414-431X2023e12922. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 37970922 Free PMC article. Review.
Cited by
-
Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers.Int J Clin Oncol. 2024 Nov;29(11):1648-1668. doi: 10.1007/s10147-024-02513-3. Epub 2024 Apr 15. Int J Clin Oncol. 2024. PMID: 38619651 Review.
-
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations.Cancers (Basel). 2023 Jan 28;15(3):808. doi: 10.3390/cancers15030808. Cancers (Basel). 2023. PMID: 36765765 Free PMC article. Review.
-
Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms.Histopathology. 2025 Jan;86(2):204-213. doi: 10.1111/his.15294. Epub 2024 Aug 5. Histopathology. 2025. PMID: 39104219 Free PMC article.
-
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.Mod Pathol. 2022 Jun;35(6):712-720. doi: 10.1038/s41379-022-01055-1. Epub 2022 Mar 5. Mod Pathol. 2022. PMID: 35249100 Free PMC article.
-
Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ.BMC Med Imaging. 2021 May 17;21(1):84. doi: 10.1186/s12880-021-00610-7. BMC Med Imaging. 2021. PMID: 34001017 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int. J. Cancer 2015; 136; E359-E386.
-
- Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406; 747-752.
-
- Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 2003; 100; 8418-8423.
-
- Cheang MC, Chia SK, Voduc D et al. Ki67 index, HER2 status, and prognosis of patients with luminal b breast cancer. J. Natl Cancer Inst. 2009; 101; 736-750.
-
- Prat A, Cheang MC, Martin M et al. Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal a breast cancer. J. Clin. Oncol. 2013; 31; 203-209.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical